Navigation Links
Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2011 Financial Results and Provides Pipeline Update
Date:11/2/2011

of the Company's nucleotide prodrugs, the Company is reallocating discovery and development resources from its protease inhibitor program to the nucleotide program. The Company will continue to evaluate potential partnerships and licensing agreements for its protease inhibitor drug candidates and related intellectual property.

Upcoming Meetings/ConferencesAmerican Association for the Study of Liver Diseases Meeting (AASLD)
Idenix will present two posters at AASLD in San Francisco, California:

  • McCarville, et al, "Patterns of NS5B mutations in a 3-day clinical trial of HCV non-nucleoside polymerase inhibitor IDX375" will be presented in a poster session on November 5, 2011 starting at 2:00pm PT
  • McCarville, et al, "In vivo resistance profile of IDX320 after 3 days of dosing in genotype 1 HCV-infected patients" will be presented in a poster session on November 5, 2011 starting at 2:00pm PT

  • HEP DART Meeting
    Idenix will have a presentation at HEP DART in Koloa, Hawaii:

  • Mayers, D. and Standring, D., "Combination DAA Strategies to Cure HCV" will be featured as an oral presentation on December 4, 2011

  • Credit Suisse 2011 Healthcare Conference
    Idenix management will present a corporate overview at the Credit Suisse 2011 Healthcare Conference on November 9, 2011 at 4:30 p.m. MST at the Arizona Biltmore Hotel, Phoenix.  

    The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.

    ABOUT IDENIX
    Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical Company engaged in the discovery and dev
    '/>"/>

    SOURCE Idenix Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
    2. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
    3. Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
    4. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
    5. Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
    6. Idenix Pharmaceuticals Initiates Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
    7. Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV
    8. Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
    9. Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results
    10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
    11. Idenix Announces Data Presentations at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/31/2015)... YORK , March 31, 2015 Immune ... announced today that it intends to expand its planned ... human monoclonal antibody targeting eotaxin-1. Bullous Pemphigoid is an ... 60,000 patients in the US and Europe ... to start enrolling patients in a Phase II clinical ...
    (Date:3/31/2015)... 2015 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... 150mg, 225mg and 300mg oral tablets, indicated for use ... market for Propafenone Hydrochloride 150mg, 225mg and 300mg tablets ... Arthur S. Przybyl , President and Chief ... launch of our fourth product from the portfolio of ...
    (Date:3/31/2015)... 2015   Unique Pharmaceuticals , a 503B outsourcing ... the company has initiated sterile compounding operations meeting the ... a company is to meet and exceed industry standards," ... the new regulations is validation of our quality management ... of our industry, investing in its continued success and ...
    Breaking Medicine Technology:Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 3Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 4ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 2Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 3
    (Date:3/31/2015)... Dr. St. Ledger recently returned from yet another trip ... Here, he participated in the Worn Dentition Workshop: a ... in cases of severely worn teeth, as well as the ... correlation to GERD and Sleep Apnea. , Dr. ... After the workshop he attended, he mentored for three days ...
    (Date:3/31/2015)... Dr. Uzma Parvez is having a busy start ... Grand Grounds Presentations at St. Michael’s Medical Center for attending ... The event was attended by a large gathering of ... feedback from the Grand Rounds. It was said that ... a while. , Ahead, Dr. Parvez has been invited ...
    (Date:3/31/2015)... OR (PRWEB) March 31, 2015 Former 49ers ... announcement than during his first year of a promising NFL ... Sports on Earth Senior Writer Will Leitch explores ... the league. Leitch talks about the decision making process that ... the preservation of health over a large paycheck, and what ...
    (Date:3/31/2015)... March 31, 2015 Greenfield Senior ... Investment Trust LLC ("Care") a seniors housing-focused real ... Inc. Care announces today, their acquisition of six ... for $54.48 million. Concurrent with the acquisition, Care ... Greenfield Senior Living ("Greenfield"). Pursuant to the lease, ...
    (Date:3/31/2015)... Nashville, TN (PRWEB) March 31, 2015 ... 16 countries have united to express their shared support ... living. Part of a 'True Health Coalition' and ... has been formed to help demonstrate that, despite appearances ... among diverse experts worldwide about the theme of healthful ...
    Breaking Medicine News(10 mins):Health News:The dentists at Upper Montclair Dental Associates are happy to announce exciting new happenings at their practice. 2Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3Health News:Greenfield Senior Living Inc. Enters Lease Transaction with Care Investment Trust LLC 2Health News:Greenfield Senior Living Inc. Enters Lease Transaction with Care Investment Trust LLC 3Health News:GLiMMER Initiative Founder David Katz, MD Announces the Launch of the True Health Coalition: Worldwide Experts Convened to Defend Fundamentals of Healthy Eating/Living 2Health News:GLiMMER Initiative Founder David Katz, MD Announces the Launch of the True Health Coalition: Worldwide Experts Convened to Defend Fundamentals of Healthy Eating/Living 3Health News:GLiMMER Initiative Founder David Katz, MD Announces the Launch of the True Health Coalition: Worldwide Experts Convened to Defend Fundamentals of Healthy Eating/Living 4
    ... very few public,health crises that can truly be cured ... one of them. There are 4.7 million people bitten ... mortality is,completely unnecessary., The American Veterinary Medical Association ... and the American Academy of Pediatrics,(AAP) in sponsoring Dog ...
    ... injured, so prevention strategies are key , , THURSDAY, May ... of falling after they leave the hospital, a New ... that prevention programs may help lower that risk. , "People ... as people who haven,t had a stroke. Falls are very ...
    ... is providing,free telephone interpretation services to anyone needing urgent ... in the,aftermath of Monday,s earthquake. The company,s British directors,currently ... support by,providing a language link for those most affected., ... 805 8503 from outside,China and 4006 88 66 99 ...
    ... appearing in the,May issue of Psychological Science, a ... being put in a low-power role may,impair a ... to,get ahead., In their article, Pamela Smith ... of VU University Amsterdam, Adam Galinsky of,the Kellogg ...
    ... Drugs for Health ... Seen Primarily in Adults, FRANKLIN LAKES, N.J., May 15 ... part by lifestyle,factors are rapidly afflicting children and leading to ... ills., New research released today by Medco Health Solutions, ...
    ... shingles cases, expert says , , THURSDAY, May 15 ... should be vaccinated against shingles, a condition that can ... Control and Prevention recommended on Thursday. , This new ... after the ZOSTAVAX vaccine was approved by the U.S. ...
    Cached Medicine News:Health News:Veterinarians, Pediatricians and Postal Workers Team Up to Reduce Incidence of Dog Bites 2Health News:Stroke Patients at High Risk for Falls 2Health News:Having Less Power Impairs the Mind and Ability to Get Ahead, Study Shows 2Health News:Kids Growing Up on Grown Up Drugs: New Research Shows Treatments for Adult Ailments Rapidly Rising in Children 2Health News:Kids Growing Up on Grown Up Drugs: New Research Shows Treatments for Adult Ailments Rapidly Rising in Children 3Health News:Kids Growing Up on Grown Up Drugs: New Research Shows Treatments for Adult Ailments Rapidly Rising in Children 4Health News:CDC Recommends Shingles Vaccine for Those Over 60 2Health News:CDC Recommends Shingles Vaccine for Those Over 60 3
    The Cordis ANGIOGUARD Capture Guidewire is the first embolic protection device shown in clinical testing to achieve a relative stroke reduction of 70% during carotid stenting procedures....
    ... point-of-care device for the qualitative detection of drug ... TOX/See device can detect up to nine of ... 8 minutes and requires only a few drops ... to maximize convenience and ease of use. TOX/See ...
    ... TOX/See™ is a 1-step, hand-held, point-of-care device ... metabolites in human urine. The TOX/See device ... commonly abused drugs in 3 to 8 minutes ... Each TOX/See cassette is individually packaged to maximize ...
    ... is a 1-step, hand-held, point-of-care device for the ... human urine. The TOX/See device can detect ... drugs in 3 to 8 minutes and requires ... cassette is individually packaged to maximize convenience and ...
    Medicine Products: